RxDoctor Payments Data

Thomas Boyd

Hematology & Oncology · Spokane, WANPI 1518049642

Payments from drug & device makers

$201,779in general payments, 2019–2025

Across 273 payments — averaging $739.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$86K
  • E.r. Squibb & Sons, L.L.C.$59K
  • Bristol Myers Squibb$24K
  • Roche Molecular Systems, Inc.$14K
  • Novartis$12K
  • AstraZeneca$3K
  • plus $4K from 26 others

What the payments were for

  • Consulting fees$48,13726%
  • Speaking & faculty fees$102,80955%
  • Travel & lodging$30,03216%
  • Food & beverage$5,9443%
  • Education$1000%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$201,779 in reported general payments places this provider in the 70th percentile of 349 hematology & oncology providers in Washington.

See all hematology & oncology providers in Washington

Other hematology & oncology in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →